Prelude Therapeutics Incorporated (PRLD)
$3.74-3.86%Close
SELLCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $294M
- Beta
- 0.96
- P/E (TTM)
- -4.82
- Short % float
- 10.96%
- Days to cover
- 7.9
- SI change
- +26.1%
- 1W
- -0.80%
- 1M
- -18.52%
- vs SPY 1W
- -1.22%
- vs SPY 1M
- -20.58%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on PRLD?
- LOPJLB’s latest quantitative signal on Prelude Therapeutics Incorporated (PRLD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PRLD in?
- Prelude Therapeutics Incorporated (PRLD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Prelude Therapeutics Incorporated (PRLD) do?
- Prelude Therapeutics, Inc. is a clinical-stage precision oncology company focused on identifying and developing innovative, targeted cancer treatments for patient populations with unmet medical needs. Its pipeline includes PRT543, currently undergoing Phase 1 clinical evaluation for certain solid tumors and myeloid malignancies. Another asset, PRT811, is also in Phase 1 trials, targeting variou…